Professional Titles and Awards

  • Medical Director, Heart Rhythm Services for Intermountain Healthcare
  • Associate Clinical Professor (Affiliated), Stanford University
  • Editor in Chief, Heart Rhythm Case Reports, Heart Rhythm Society
  • Columnist, Rhythm of Life, Everyday Health
  • Recipient, Donald C. Balfour Award for Meritorius Research

Research and Professional Experience

Dr. Bunch served as an Assistant Professor of Medicine at the Mayo Clinic from 2003-2007, before joining his current partners at Intermountain Medical Center Heart Institute, Heart Rhythm Specialists. He currently directs heart rhythm services and research for Intermountain Healthcare. Dr. Bunch is also an Affiliated Clinical Associate Professor for Stanford University.

Dr. Bunch is the founding editor of the Heart Rhythm Case Reports Journal. He serves on the editorial boards of the Heart Rhythm Journal, Journal of Cardiovascular Electrophysiology, American Heart Journal, JACC Electrophysiology, and the Journal of Innovations in Cardiac Rhythm Management.

Dr. Bunch is interested in the management of atrial and ventricular arrhythmia. In particular, he focuses on nonpharmacologic strategies such as catheter ablation, and in enhancing the safety of both pharmacologic and nonpharmacologic treatments. His current research involves defining mechanisms that underly the association of atrial fibrillation and dementia and looking at therapeutic opportunities to lower risk of cognitive decline.

Dr. Bunch is involved in multiple national and international trials involving cardiac rhythm management. He has published over 140 manuscripts, 10 book chapters, and presented over 150 national and international abstracts on these topics.

Current Research Projects

  • CAF Trial: This study will assess the effect of two FDA-approved drugs (Dabigatran and Warfarin) that prevent clotting of blood on the awareness, understanding, memory and intellectual capability of patients with irregular heartbeats.
  • CABANA: This trial has the overall goal of establishing the appropriate roles for medical and ablative intervention for atrial fibrillation. We are the second leading enrollment center in the world.